ArticleJournal of medical systems2026
End-to-End Multimodal Multiple Instance Learning for Cancer Histopathology Classification with Dual-Attention Fusion.
Article in Journal of medical systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In recent years, computational pathology has advanced toward integrating histopathological images and genomic data to improve diagnostic accuracy and biological interpretability. In this study, we propose a lightweight end-to-end multi-instance learning model that integrates whole slide images (WSIs) with gene expression profiles. The proposed method efficiently extracts image features using a reduced MobileNetV4 and treats gene information at the gene set level based on Gene Set Enrichment Analysis (GSEA) to capture functional relationships among genes. Image and gene features are aggregated within and across modalities through self-attention and cross-attention mechanisms. Our experiments on three cancer types, namely low-grade glioma (LGG), non-small cell lung cancer (NSCLC), and breast cancer (BRCA) showed that the proposed model outperformed image-only models and conventional single-vector gene input models. In particular, the ROC-AUC reached 0.740 for LGG, 0.982 for NSCLC, and 0.966 for BRCA, with a notable improvement in PR-AUC observed for BRCA classification. These results indicate that the integration of morphological and molecular information is effective for capturing disease characteristics. Furthermore, the proposed model maintains high classification performance while reducing computational resources, suggesting its potential applicability to large-scale pathological datasets and clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.